Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Hepatic Oncology is Scopus-indexed (Q3, CiteScore 1.8), WoS ESCI, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2045-0923Verify ISSN ↗2045-0931Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 301 / 428 | 29th | Q3 |
| Hepatology | 63 / 88 | 28th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present (also 2020, 2016), best quartile Q3, CiteScore 1.8.
Hepatic Oncology is Q3 in Oncology (rank 301 of 428) and Q3 in Hepatology (rank 63 of 88), by CiteScore 2025.
Hepatic Oncology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.8, which places it in quartile Q3 at the 29th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.411, quartile Q3, with an H-index of 5.
The publisher lists an article processing charge of about US$1,415 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Hepatic Oncology is published by Taylor and Francis Ltd. Its print ISSN is 2045-0923 and its online ISSN is 2045-0931.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Hepatic Oncology has an h-index of 26 and a 2-year mean of 2.63 citations per paper (OpenAlex). Its Scopus CiteScore is 1.8, quartile Q3. On 2-year citations it ranks #141 of 424 Scopus journals in Oncology.
Hepatic Oncology published 8 papers in 2025; its busiest recent year was 2020 with 22. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 33 research articles (2021–2026), authors are most often from United States (50.8%), China (11.6%) and Spain (4.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.